Beyond the first glance: anthracyclines in AML

被引：4
作者：
Fernandez, Hugo F. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
BLOOD | 2015年 / 125卷 / 25期
关键词：
HIGH-DOSE DAUNORUBICIN; CYTOSINE-ARABINOSIDE; INDUCTION; STANDARD; TRIAL;
D O I：
10.1182/blood-2015-04-639419
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3828 / +
页数：2
相关论文
共 10 条
  • [1] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [2] A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients
    Burnett, Alan K.
    Russell, Nigel H.
    Hills, Robert K.
    Kell, Jonathan
    Cavenagh, Jamie
    Kjeldsen, Lars
    McMullin, Mary-Frances
    Cahalin, Paul
    Dennis, Mike
    Friis, Lone
    Thomas, Ian F.
    Milligan, Don
    Clark, Richard E.
    [J]. BLOOD, 2015, 125 (25) : 3878 - 3885
  • [3] Anthracycline Dose Intensification in Acute Myeloid Leukemia
    Fernandez, Hugo F.
    Sun, Zhuoxin
    Yao, Xiaopan
    Litzow, Mark R.
    Luger, Selina M.
    Paietta, Elisabeth M.
    Racevskis, Janis
    Dewald, Gordon W.
    Ketterling, Rhett P.
    Bennett, John M.
    Rowe, Jacob M.
    Lazarus, Hillard M.
    Tallman, Martin S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) : 1249 - 1259
  • [4] Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10)
    Hann, IM
    Stevens, RF
    Goldstone, AH
    Rees, JKH
    Wheatley, K
    Gray, RG
    Burnett, AK
    [J]. BLOOD, 1997, 89 (07) : 2311 - 2318
  • [5] A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia
    Lee, Je-Hwan
    Joo, Young-Don
    Kim, Hawk
    Bae, Sung Hwa
    Kim, Min Kyoung
    Zang, Dae Young
    Lee, Jung-Lim
    Lee, Gyeong Won
    Lee, Jung-Hee
    Park, Jae-Hoo
    Kim, Dae-Young
    Lee, Won-Sik
    Ryoo, Hun Mo
    Hyun, Myung Soo
    Kim, Hyo Jung
    Min, Young Joo
    Jang, Yae-Eun
    Lee, Kyoo-Hyung
    [J]. BLOOD, 2011, 118 (14) : 3832 - 3841
  • [6] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    van Putten, Wim
    Schouten, Harry C.
    Graux, Carlos
    Ferrant, Augustin
    Sonneveld, Pieter
    Maertens, Johan
    Jongen-Lavrencic, Mojca
    von Lilienfeld-Toal, Marie
    Biemond, Bart J.
    Vellenga, Edo
    Kooy, Marinus van Marwijk
    Verdonck, Leo F.
    Beck, Joachim
    Doehner, Hartmut
    Gratwohl, Alois
    Pabst, Thomas
    Verhoef, Gregor
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) : 1235 - 1248
  • [7] Luskin MR, 2014, BLOOD, V124
  • [8] Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
    Mandelli, Franco
    Vignetti, Marco
    Suciu, Stefan
    Stasi, Roberto
    Petti, Maria-Concetta
    Meloni, Giovanna
    Muus, Petra
    Marmont, Filippo
    Marie, Jean-Pierre
    Labar, Boris
    Thomas, Xavier
    Di Raimondo, Francesco
    Willemze, Roel
    Liso, Vincenzo
    Ferrara, Felicetto
    Baila, Liliana
    Fazi, Paola
    Zittoun, Robert
    Amadori, Sergio
    de Witte, Theo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5397 - 5403
  • [9] A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study
    Weick, JK
    Kopecky, KJ
    Appelbaum, FR
    Head, DR
    Kingsbury, LL
    Balcerzak, SP
    Bickers, JN
    Hynes, HE
    Welborn, JL
    Simon, SR
    Grever, M
    [J]. BLOOD, 1996, 88 (08) : 2841 - 2851
  • [10] YATES JW, 1973, CANCER CHEMOTH REP 1, V57, P485
1